|
ALX-210-108 |
PAb to Vitamin D3 Receptor |
|
|
|
ALX-210-117 |
PAb to PPAR |
|
|
|
ALX-210-131 |
PAb to Glucocorticoid Receptor |
|
|
|
ALX-210-132 |
PAb to Estrogen Receptor β |
|
|
|
ALX-210-135 |
PAb to Estrogen Receptor β |
|
|
|
ALX-210-151 |
PAb to Androgen Receptor |
|
|
|
ALX-210-152/1 |
PAb to Androgen Receptor |
|
|
|
ALX-210-153 |
PAb to Glucocorticoid Receptor |
|
|
|
ALX-210-154 |
PAb to Glucocorticoid Receptor β (human) |
|
|
|
ALX-210-155 |
PAb to Glucocorticoid Receptor |
|
|
|
ALX-210-156/1 |
PAb to Retinoic Acid Receptor α |
|
|
|
ALX-210-157 |
PAb to Retinoic Acid Receptor β |
|
|
|
ALX-210-158 |
PAb to Retinoic Acid Receptor γ-1 (human) |
|
|
|
ALX-210-159 |
PAb to Retinoic Acid Receptor γ-2 (human) |
|
|
|
ALX-210-160 |
PAb to Retinoid X Receptor β |
|
|
|
ALX-210-163 |
PAb to Thyroid Hormone Receptor α-1 |
|
|
|
ALX-210-165 |
PAb to Thyroid Hormone Receptor β-1 |
|
|
|
ALX-210-178 |
PAb to Estrogen Receptor β |
|
|
|
ALX-210-180 |
PAb to Estrogen Receptor β |
|
|
|
ALX-210-190/1 |
PAb to PPARα (mouse) |
|
|
|
ALX-210-191/1 |
PAb to PPARδ (mouse) |
|
|
|
ALX-210-192 |
PAb to PPARγ2 (mouse) |
|
|
|
ALX-210-201 |
PAb to Estrogen Receptor α |
|
|
|
ALX-210-202 |
PAb to Estrogen Receptor α |
|
|
|
ALX-210-225 |
PAb to PPARγ |
|
|
|
ALX-210-255 |
PAb to AIB1 (human) |
|
|
|
ALX-210-261 |
PAb to MCAD |
|
|
|
ALX-210-277 |
PAb to Glucocorticoid Receptor α |
|
|
|
ALX-210-283 |
PAb to SRC-1 |
|
|
|
ALX-210-286 |
PAb to Glucocorticoid Receptor Interacting Protein 1 |
|
|
|
ALX-210-361 |
PAb to PPARα (mouse) (phosphorylated) (pSer12) |
|
|
|
ALX-210-362 |
PAb to PPARα (mouse) (phosphorylated) (pSer21) |
|
|
|
ALX-210-462 |
Polyclonal Antibody to TRB-3 (human) |
|
|
|
ALX-210-954 |
PAb to WIPI-1 (human) (AT129) |
|
|
|
ALX-210-955 |
PAb to WIPI-1 (AT130) |
|
|
|
ALX-270-102 |
Naproxen |
|
|
|
ALX-270-198 |
WY-14,643 |
|
|
|
ALX-270-255 |
Ciglitazone |
|
|
|
ALX-270-256 |
Clofibrate |
|
|
|
ALX-270-264 |
Carnosic acid |
|
|
|
ALX-270-309 |
T0901317 |
|
|
|
ALX-270-312 |
Formononetin (high purity) |
|
|
|
ALX-270-353 |
BADGE |
|
|
|
ALX-270-355 |
Troglitazone |
|
|
|
ALX-270-356 |
GW9662 |
|
|
|
ALX-270-367 |
Pioglitazone |
|
|
|
ALX-270-368 |
MK-886 |
|
|
|
ALX-270-474 |
HSD Inhibitor 23 |
|
|
|
ALX-270-475 |
Ciprofibrate |
|
|
|
ALX-270-476 |
Bicalutamide |
|
|
|
ALX-270-481 |
Fenofibrate |
|
|
|
ALX-300-150 |
Oleoylethanolamide |
|
|
|
ALX-300-301 |
PAz-PC |
|
|
|
ALX-301-013 |
Azelaoyl-PAF |
|
|
|
ALX-340-010 |
ETYA |
|
|
|
ALX-340-022 |
Prostaglandin J2, 15-Deoxy-Δ12,14- |
|
|
|
ALX-340-026 |
LY-171,883 |
|
|
|
ALX-340-037 |
8(S)-HETE |
|
|
|
ALX-340-038 |
Leukotriene B4 |
|
|
|
ALX-350-097 |
Hyperforin . dicyclohexylammonium salt (high purity) |
|
|
|
ALX-350-098 |
Ferutinin (high purity) |
|
|
|
ALX-350-103 |
Rosiglitazone . maleate |
|
|
|
ALX-350-108 |
Pseudolaric acid B |
|
|
|
ALX-350-125 |
Rosiglitazone |
|
|
|
ALX-350-147 |
Bavachin |
|
|
|
ALX-350-279 |
Isoxanthohumol |
|
|
|
ALX-350-280 |
Xanthohumol |
|
|
|
ALX-350-361 |
Auraptene |
|
|
|
ALX-370-002 |
Dexamethasone |
|
|
|
ALX-370-007 |
Corticosterone |
|
|
|
ALX-380-092 |
Radicicol |
|
|
|
ALX-385-025 |
8-Isopentenylnaringenin |
|
|
|
ALX-385-032 |
(R,S)-Equol |
|
|
|
ALX-420-029 |
GW1929 |
|
|
|
ALX-420-032 |
GW501516 |
|
|
|
ALX-460-025 |
Vitamin D2 |
|
|
|
ALX-460-026 |
Vitamin D3 |
|
|
|
ALX-460-032 |
Calcitriol |
|
|
|
ALX-460-036 |
Alfacalcidol |
|
|
|
ALX-550-095 |
Tamoxifen . citrate |
|
|
|
ALX-550-361 |
(Z)-4-Hydroxytamoxifen |
|
|
|
ALX-550-516 |
Compound A |
|
|
|
ALX-748-003 |
PPARγ (human) cDNA Probe |
|
|
|
ALX-803-004 |
MAb to Estrogen Receptor α (33) |
|
|
|
ALX-803-006 |
MAb to Glucocorticoid Receptor (BuGR2) |
|
|
|
ALX-803-007 |
MAb to Progesterone Receptor (PR-AT 4.14) |
|
|
|
ALX-803-010 |
MAb to Progesterone Receptor (αPR6) |
|
|
|
ALX-803-011 |
MAb to Progesterone Receptor (chicken) (αPR22) |
|
|
|
ALX-803-043 |
MAb to Progesterone Receptor (human) (phosphorylated) (pSer190) (1154) |
|
|
|
ALX-803-044 |
MAb to Progesterone Receptor (human) (phosphorylated) (pSer294) (608) |
|
|
|
ALX-804-021 |
MAb to Vitamin D3 Receptor (9A7) |
|
|
|
ALX-804-097 |
MAb to Androgen Receptor (AN1-15) |
|
|
|
ALX-804-098 |
MAb to CRABP1 (C-1) |
|
|
|
ALX-804-099 |
MAb to Mineralocorticoid (Aldosterone) Receptor (H10E4C9F) |
|
|
|
ALX-804-102 |
MAb to Retinoic Acid Receptor α (Rα10) |
|
|
|
ALX-804-103 |
MAb to Retinoic Acid Receptor β (Rβ28) |
|
|
|
ALX-804-104 |
MAb to Retinoid X Receptor β (MOK13-17) |
|
|
|
ALX-804-191 |
MAb to SRC-1 (1135/H4) |
|
|
|
ALX-804-255 |
MAb to PPARα (3B6/PPAR) |
|
|
|
ALX-804-283 |
MAb to AIB1 (human) (AX15.3) |
|
|
|
ALX-804-442 |
MAb to Retinoic Acid Receptor α (human) (763) |
|
|
|
ALX-804-443 |
MAb to Retinoic Acid Receptor β (human) (336) |
|
|
|
ALX-804-444 |
MAb to Retinoid X Receptor γ (human) (1373) |
|
|
|
ALX-804-589 |
MAb to SHP (human) (SH2G5-C) |
|
|
|
ALX-804-644 |
MAb to RORα (human) (6E8) |
|
|
|
ALX-850-021 |
Glucocorticoid Receptor Discovery Kit |
|
|
|
ALX-BC-6010-S |
MAb to Thyroid Peroxidase (human) (TPO 47) |
|
|
